Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsOPHTHALMICStandard

GENTAMICIN SULFATE

GENTAMICIN SULFATE

Standard Dose
EQ 0.3% BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription

Key Takeaways

  • Primary indication: Marketing status: Prescription
  • Approval overview GENTAMICIN SULFATE is listed in Drugs@FDA under application 065024 (ANDA).
  • Marketing status: Prescription Active ingredient GENTAMICIN SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 0.3% BASE Sponsor FERA PHARMS LLC Submission history Latest submission status date: 2004-07-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview GENTAMICIN SULFATE is listed in Drugs@FDA under application 065024 (ANDA). Marketing status: Prescription Active ingredient GENTAMICIN SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 0.3% BASE Sponsor FERA PHARMS LLC Submission history Latest submission status date: 2004-07-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: UNKNOWN
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.